Multi-site comparison of parametric T1 and T2 mapping: healthy travelling volunteers in the Berlin research network for cardiovascular magnetic resonance (BER-CMR)

[11] Rogers T(2013)Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 62 1280-1356

[12] Kathirgamanathan M(2017)Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) J Cardiovasc Magn Reson 19 75-275

[13] Messroghli DR(2014)Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study J Cardiovasc Magn Reson 16 69-2170

[14] Radjenovic A(2017)Influence of spatial resolution and contrast agent dosage on myocardial T1 relaxation times Magma N Y N 30 85-155

[15] Kozerke S(2020)Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: normal behavior and validation in patients with amyloidosis J Cardiovasc Magn Reson 22 6-159

[16] Higgins DM(2005)Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging Radiology 235 229-351

[17] Sivananthan MU(2007)Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart J Magn Reson Imaging JMRI 26 1081-538

[18] Ridgway JP(2020)Cardiac T1 mapping: techniques and applications J Magn Reson Imaging JMRI 51 1336-1391

[19] Kellman P(2022)T2 mapping in myocardial disease: a comprehensive review J Cardiovasc Magn Reson 24 33-68

[20] Hansen MS(2013)Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications J Cardiovasc Magn Reson 18 53-222

[11] Rogers T(2013)Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 62 1280-1356

[12] Kathirgamanathan M(2017)Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) J Cardiovasc Magn Reson 19 75-275

[13] Messroghli DR(2014)Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study J Cardiovasc Magn Reson 16 69-2170

[14] Radjenovic A(2017)Influence of spatial resolution and contrast agent dosage on myocardial T1 relaxation times Magma N Y N 30 85-155

[15] Kozerke S(2020)Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: normal behavior and validation in patients with amyloidosis J Cardiovasc Magn Reson 22 6-159

[16] Higgins DM(2005)Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging Radiology 235 229-351

[17] Sivananthan MU(2007)Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart J Magn Reson Imaging JMRI 26 1081-538

[18] Ridgway JP(2020)Cardiac T1 mapping: techniques and applications J Magn Reson Imaging JMRI 51 1336-1391

[19] Kellman P(2022)T2 mapping in myocardial disease: a comprehensive review J Cardiovasc Magn Reson 24 33-68

[20] Hansen MS(2013)Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications J Cardiovasc Magn Reson 18 53-222